{"id":105364,"date":"2019-03-12T17:47:31","date_gmt":"2019-03-12T17:47:31","guid":{"rendered":"https:\/\/bioengineer.org\/international-congress-of-myology-2019\/"},"modified":"2019-03-12T17:47:31","modified_gmt":"2019-03-12T17:47:31","slug":"international-congress-of-myology-2019","status":"publish","type":"post","link":"https:\/\/bioengineer.org\/international-congress-of-myology-2019\/","title":{"rendered":"International congress of Myology 2019"},"content":{"rendered":"

At Bordeaux (France) from March 25 to 28, 2019<\/p>\n

<\/p>\n

\n

During the 3 days of plenary sessions and thematic symposia of Myology 2019, more than 70 scientist speakers from the United States, Japan, France, Italy, England, Germany, Spain, the Netherlands, Russia, Brazil… will testify before 800 scientists.<\/p>\n

We know it, a new era is opening up for rare diseases that were regarded as incurable till recently, and MYOLOGY 2019 will reflect this change of paradigm for sure.<\/p>\n

That is why we really look forward to having you in even more significant numbers for this 2019 edition in Bordeaux.\n<\/p>\n

Only an international alliance of researchers, clinicians and patients is able to concretize new victories against disease and to speed up the pace of the ongoing medical and scientific revolution.\n<\/p>\n

###<\/p>\n<\/p><\/div>\n

Media Contact<\/strong>
St\u00e9phanie Bardon
sbardon@afm-telethon.fr
https:\/\/www.afm-telethon.fr\/actualites\/press-invitation-international-congress-myology-2019-127170 <\/i><\/wbr><\/wbr><\/wbr><\/wbr><\/wbr><\/wbr><\/p>\n","protected":false},"excerpt":{"rendered":"

At Bordeaux (France) from March 25 to 28, 2019 During the 3 days of plenary sessions and thematic symposia of Myology 2019, more than 70 scientist speakers from the United States, Japan, France, Italy, England, Germany, Spain, the Netherlands, Russia, Brazil… will testify before 800 scientists. We know it, a new era is opening up […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_review":[],"enable_review":"","type":"","name":"","summary":"","brand":"","sku":"","good":[],"bad":[],"score_override":"","override_value":"","rating":[],"price":[],"jnews_override_counter":[],"footnotes":""},"categories":[251],"tags":[305,312,295,311,325,307,322],"class_list":["post-105364","post","type-post","status-publish","format-standard","hentry","category-health","tag-biotechnology","tag-cell-biology","tag-clinical-trials","tag-gene-therapy","tag-genes","tag-genetics","tag-molecular-biology"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/105364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/comments?post=105364"}],"version-history":[{"count":0,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/105364\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/media?parent=105364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/categories?post=105364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/tags?post=105364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}